CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GOSS | Gossamer Bio INC | Stock-Other | 39.34% | — | — | |
| 2 | REPL | Replimune Group INC | Stock-Other | 19.02% | +0.33% | — | |
| 3 | MORFUSD | Morphic Holding INC | Stock-Other | 15.01% | — | — | |
| 4 | ✓ | Translate Bio INC | Stock-Other | 7.85% | — | — | |
| 5 | VTLUSD | Immunic INC | Stock-Other | 4.01% | — | — | |
| 6 | ✓ | Obseva SA | Stock-Other | 2.88% | — | — | |
| 7 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 2.65% | — | — | |
| 8 | TRVI | Trevi Therapeutics INC | Stock-Other | 2.42% | — | — | |
| 9 | ✓ | Prevail Therapeutics INC | Stock-Other | 2.25% | — | — | |
| 10 | FGENEUR | Fibrogen INC | Stock-Other | 1.51% | — | — | |
| 11 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 0.90% | — | -3.05% | |
| 12 | EPIEUR | Essa Pharma INC | Stock-Other | 0.68% | — | — | |
| 13 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 0.67% | — | — | |
| 14 | ✓ | Cidara Therapeutics INC Com New | Stock-Other | 0.65% | — | — | |
| 15 | SNNAQ | Sienna Biopharmaceuticals In | Stock-Other | 0.17% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PIRSEUR | Pieris Pharmaceuticals INC | +0.1% | -3.05% | Trim |
| 2 | ✓ | Translate Bio INC | -0.1% | — | Unchanged |
| 3 | JNCEEUR | Jounce Therapeutics INC | -0.4% | — | Unchanged |
| 4 | SNNAQ | Sienna Biopharmaceuticals In | -0.4% | — | Unchanged |
| 5 | EPIEUR | Essa Pharma INC | -0.5% | — | Unchanged |
| 6 | ✓ | Cidara Therapeutics INC Com New | -0.6% | — | Unchanged |
| 7 | FGENEUR | Fibrogen INC | -0.8% | — | Unchanged |
| 8 | ✓ | Obseva SA | -1.2% | — | Unchanged |
| 9 | PRTKEUR | Paratek Pharmaceuticals INC | -1.8% | — | Unchanged |
| 10 | REPL | Replimune Group INC | -5.8% | — | Unchanged |
| 11 | GOSS | Gossamer Bio INC | -9% | — | Unchanged |
| 12 | MORFUSD | Morphic Holding INC | — | NEW | New buy |
| 13 | VTLUSD | Immunic INC | — | NEW | New buy |
| 14 | TRVI | Trevi Therapeutics INC | — | NEW | New buy |
| 15 | ✓ | Prevail Therapeutics INC | — | NEW | New buy |
| 16 | CBAYUSD | Cymabay Therapeutics INC | — | EXIT | Sold out |
| 17 | DRNAUSD | Dicerna Pharmaceuticals INC | — | EXIT | Sold out |